- Home
- LAC vs IAM Comparison
LAC vs IAM Comparison
Compare LAC & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAC | IAM |
|---|---|---|
| Founded | 2023 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 686.2M | 683.0M |
| IPO Year | 2023 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LAC | IAM |
|---|---|---|
| Price | $1.67 | $15.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | $5.07 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 7.5M | 648.2K |
| Earning Date | 11-13-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $225.80 |
| Revenue Next Year | N/A | $150.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.78 | $9.60 |
| 52 Week High | $6.96 | $24.49 |
Technical Indicators
Market Signals| Indicator | LAC | IAM |
|---|---|---|
| Relative Strength Index (RSI) | 29.45 | 33.63 |
| Support Level | N/A | $12.52 |
| Resistance Level | $2.22 | $16.50 |
| Average True Range (ATR) | 0.13 | 1.84 |
| MACD | 0.00 | 0.31 |
| Stochastic Oscillator | 1.85 | 79.71 |
Price Performance
Historical ComparisonAbout LAC Lithium Americas Corp.
Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.
About IAM Iambic Therapeutics Inc. Common Stock
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.